Joanna Loizou’s group is investigating how the DNA damage response can be targeted in patients with breast cancer to improve treatments.
Joanna Loizou is Deputy Director of the Centre for Target Validation and Group Leader across the Divisions of Cancer Therapeutics and Breast Cancer Research where her team aims to identify interactions within the DNA damage response that can be used to treat cancer.